0

Journal Articles

in Psychosis
 41-60 of 148 Articles
Original Article |  July 01, 2010 FREE
Psychosis Susceptibility Gene ZNF804A and Cognitive Performance in Schizophrenia
James T. R. Walters, MRCPsych, BM; Aiden Corvin, MRCPsych, PhD; Michael J. Owen, FRCPsych; et al.
Arch Gen Psychiatry. 2010;67(7):692-700. doi:10.1001/archgenpsychiatry.2010.81.
Original Article |  June 01, 2010 FREE
Neuropsychology of the Prodrome to Psychosis in the NAPLS Consortium:  Relationship to Family History and Conversion to Psychosis
Larry J. Seidman, PhD; Anthony J. Giuliano, PhD; Eric C. Meyer, PhD; et al.
Arch Gen Psychiatry. 2010;67(6):578-588. doi:10.1001/archgenpsychiatry.2010.66.
INCLUDES: , Supplemental Content
Original Article |  May 01, 2010 FREE
Association Between Cannabis Use and Psychosis-Related Outcomes Using Sibling Pair Analysis in a Cohort of Young Adults
John McGrath, MD, PhD, FRANZCP; Joy Welham, MAPs; James Scott, MBBS, FRANZCP; et al.
Arch Gen Psychiatry. 2010;67(5):440-447. doi:10.1001/archgenpsychiatry.2010.6.
INCLUDES: , Supplemental Content
Original Article |  May 01, 2010 FREE
Specificity of Familial Transmission of Schizophrenia Psychosis Spectrum and Affective Psychoses in the New England Family Study’s High-Risk Design
Jill M. Goldstein, PhD; Stephen L. Buka, ScD; Larry J. Seidman, PhD; et al.
Arch Gen Psychiatry. 2010;67(5):458-467. doi:10.1001/archgenpsychiatry.2010.38.
Original Article |  April 01, 2010 FREE
Etiological and Clinical Features of Childhood Psychotic Symptoms:  Results From a Birth Cohort
Guilherme Polanczyk, MD, PhD; Terrie E. Moffitt, PhD; Louise Arseneault, PhD; et al.
Arch Gen Psychiatry. 2010;67(4):328-338. doi:10.1001/archgenpsychiatry.2010.14.
Original Article |  March 01, 2010 FREE
Prediction of Psychosis in Adolescents and Young Adults at High Risk:  Results From the Prospective European Prediction of Psychosis Study
Stephan Ruhrmann, MD; Frauke Schultze-Lutter, PhD; Raimo K. R. Salokangas, MD, PhD, MSc; et al.
Arch Gen Psychiatry. 2010;67(3):241-251. doi:10.1001/archgenpsychiatry.2009.206.
INCLUDES: , Supplemental Content
Original Article |  February 01, 2010 FREE
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders:  A Randomized, Placebo-Controlled Trial
G. Paul Amminger, MD; Miriam R. Schäfer, MD; Konstantinos Papageorgiou, MD; et al.
Arch Gen Psychiatry. 2010;67(2):146-154. doi:10.1001/archgenpsychiatry.2009.192.
Original Article |  January 01, 2010 FREE
Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia
Hans Rasmussen, PhD; David Erritzoe, MD, PhD; Rune Andersen, MSc; et al.
Arch Gen Psychiatry. 2010;67(1):9. doi:10.1001/archgenpsychiatry.2009.176.
Review |  November 01, 2009
The Catatonia Syndrome:  Forgotten but Not Gone
Max Fink, MD; Michael Alan Taylor, MD
Arch Gen Psychiatry. 2009;66(11):1173-1177. doi:10.1001/archgenpsychiatry.2009.141.
Original Article |  September 01, 2009 FREE
Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders
Scott A. Schobel, MD; Nicole M. Lewandowski, PhD; Cheryl M. Corcoran, MD; et al.
Arch Gen Psychiatry. 2009;66(9):938-946. doi:10.1001/archgenpsychiatry.2009.115.
Original Article |  August 01, 2009 FREE
A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression:  The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
Barnett S. Meyers, MD; Alastair J. Flint, MD; Anthony J. Rothschild, MD; et al.
Arch Gen Psychiatry. 2009;66(8):838-847. doi:10.1001/archgenpsychiatry.2009.79.
Original Article |  July 01, 2009 FREE
Use of Neuroanatomical Pattern Classification to Identify Subjects in At-Risk Mental States of Psychosis and Predict Disease Transition
Nikolaos Koutsouleris, MD; Eva M. Meisenzahl, MD; Christos Davatzikos, PhD; et al.
Arch Gen Psychiatry. 2009;66(7):700-712. doi:10.1001/archgenpsychiatry.2009.62.
INCLUDES: , Supplemental Content
Original Article |  June 01, 2009 FREE
The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors:  A Positron Emission Tomography Study With [11C]-(+)-PHNO
Ariel Graff-Guerrero, MD, PhD; David Mamo, MD, MSc; C. M. Shammi, MD; et al.
Arch Gen Psychiatry. 2009;66(6):606-615. doi:10.1001/archgenpsychiatry.2009.43.
INCLUDES: , Supplemental Content
Original Article |  May 01, 2009 FREE
Prospective Study of Peer Victimization in Childhood and Psychotic Symptoms in a Nonclinical Population at Age 12 Years
Andrea Schreier, PhD; Dieter Wolke, PhD; Kate Thomas, MSc; et al.
Arch Gen Psychiatry. 2009;66(5):527-536. doi:10.1001/archgenpsychiatry.2009.23.
Original Article |  April 01, 2009 FREE
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol:  A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya, MD; Paolo Fusar-Poli, MD; Stefan Borgwardt, MD; et al.
Arch Gen Psychiatry. 2009;66(4):442-451. doi:10.1001/archgenpsychiatry.2009.17.
INCLUDES: , Supplemental Content
Original Article |  April 01, 2009 FREE
Progressive Gray Matter Reduction of the Superior Temporal Gyrus During Transition to Psychosis
Tsutomu Takahashi, MD, PhD; Stephen J. Wood, PhD; Alison R. Yung, MD, MPM, FRANZCP; et al.
Arch Gen Psychiatry. 2009;66(4):366-376. doi:10.1001/archgenpsychiatry.2009.12.
INCLUDES: , Supplemental Content
Original Article |  February 01, 2009 FREE
Association of Variants in DISC1 With Psychosis-Related Traits in a Large Population Cohort
Liisa Tomppo, BM; William Hennah, PhD; Jouko Miettunen, PhD; et al.
Arch Gen Psychiatry. 2009;66(2):134-141. doi:10.1001/archgenpsychiatry.2008.524.
Original Article |  November 03, 2008 FREE
Raised Incidence Rates of All Psychoses Among Migrant Groups:  Findings From the East London First Episode Psychosis Study
Jeremy W. Coid, MD; James B. Kirkbride, PhD; Dave Barker, MRCPsych; et al.
Arch Gen Psychiatry. 2008;65(11):1250-1258. doi:10.1001/archpsyc.65.11.1250.
Original Article |  November 03, 2008 FREE
Familial Predisposition for Psychiatric Disorder:  Comparison of Subjects Treated for Cannabis-Induced Psychosis and Schizophrenia
Mikkel Arendt, MScPsych, PhD; Preben B. Mortensen, DrMedSc; Raben Rosenberg, DrMedSc; et al.
Arch Gen Psychiatry. 2008;65(11):1269-1274. doi:10.1001/archpsyc.65.11.1269.
Original Article |  October 06, 2008 FREE
Effects of Second-Generation Antipsychotic Medication on Smooth Pursuit Performance in Antipsychotic-Naive Schizophrenia
Rebekka Lencer, MD; Andreas Sprenger, MA; Margret S. H. Harris, MA; et al.
Arch Gen Psychiatry. 2008;65(10):1146-1154. doi:10.1001/archpsyc.65.10.1146.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Research Letters  |  February 6, 2013
Antipsychotic Use Among Nursing Home Residents
Becky A. Briesacher, PhD; Jennifer Tjia, MD, MSCE; Terry Field, DSc; et al.
JAMA
Capitol Health Call  |  November 14, 2012
Overprescribing Antipsychotics
Mike Mitka, MSJ
JAMA
Medical News and Perspectives  |  July 11, 2012
CMS Seeks to Reduce Antipsychotic Use in Nursing Home Residents With Dementia
Mike Mitka
JAMA Internal Medicine
Invited Commentary  |  Apr 23, 2012
From Association to Mechanism:  Comment on “Antipsychotic Use and Myocardial Infarction in Older Patients With Treated Dementia”
Sudeep S. Gill, MD, MSc; Dallas P. Seitz, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems